Checkmate Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, announced the appointment of Alan Bash as President and Chief Executive Officer, effective March 1, 2022.
February 9, 2022
· 6 min read